GHRP-6 vs Hexarelin

GHRP-6 is one of the original synthetic growth hormone releasing peptides, a hexapeptide that acts through the ghrelin receptor (GHS-R1a) to stimulate growth hormone release from the pituitary. It also has documented effects on appetite stimulation through hypothalamic ghrelin signaling, making it a research tool for both GH biology and feeding behavior studies. Hexarelin is a synthetic hexapeptide developed as a more potent successor to GHRP-6, with structural modifications that enhance receptor affinity and metabolic stability. Beyond its GH-releasing activity, hexarelin has been shown to bind the CD36 receptor in cardiac tissue, leading to a body of cardioprotective research independent of its GH-mediated effects. It is one of the most potent ghrelin mimetics in the GHRP class.

GHRP-6

Class Original ghrelin mimetic
Potency Moderate
Appetite Effects Strong (hypothalamic ghrelin)
Cardiac Receptor Activity Minimal
Research Focus GH release, appetite biology
Cortisol Effect Mild

Hexarelin

Class Modified, more potent ghrelin mimetic
Potency High (more potent than GHRP-6)
Appetite Effects Present but less prominent
Cardiac Receptor Activity CD36 binding (cardioprotective research)
Research Focus GH release, cardiac, multi-pathway
Cortisol Effect Significant

The Verdict

GHRP-6 and hexarelin both act through the ghrelin receptor but differ in potency and secondary effects. GHRP-6 is the more accessible tool for studying ghrelin-mediated appetite biology, with strong hypothalamic effects on feeding behavior. Hexarelin offers higher potency for GH research and additional cardiac mechanisms through CD36 binding, making it appropriate for multi-pathway studies. Researchers focused on appetite regulation typically prefer GHRP-6, while those investigating cardiac or multi-target effects may select hexarelin.

Explore These Products

GHRP-6

A synthetic hexapeptide ghrelin receptor agonist studied for its ability to stimulate growth hormone release from the anterior pituitary in research models.

View Details →

Hexarelin

A synthetic hexapeptide and one of the most potent growth hormone-releasing peptides studied, with additional cardioprotective properties via CD36 receptor binding.

View Details →

GHRP-6 vs Hexarelin — FAQ

Why is hexarelin more potent than GHRP-6?
Hexarelin has structural modifications including a methylated tryptophan that enhance ghrelin receptor binding affinity and improve metabolic stability compared to the original GHRP-6 sequence.
What is the cardiac connection with hexarelin?
Hexarelin binds CD36 receptors in cardiac tissue, which has been studied for cardioprotective signaling independent of growth hormone release. This dual receptor activity is unique among GHRPs.
Do both stimulate appetite?
GHRP-6 has stronger documented effects on appetite stimulation through hypothalamic ghrelin pathways. Hexarelin has appetite-modulating activity but it is generally less prominent than its GH-releasing effects.
What is the regulatory status?
Both are sold as research-use-only compounds for in-vitro and preclinical study models.

References

Primary sources for key clinical and regulatory claims on this page.

  1. Effects of growth hormone-releasing peptide-6 on the GH-IGF-1 axis — PubMed / J Endocrinol . Foundational reference for GHRP-6 mechanism and appetite-stimulating effects.
  2. Hexarelin: a synthetic GH-releasing peptide with multiple actions — PubMed / J Endocrinol Invest . Primary reference for hexarelin GH-releasing potency and cardiac CD36 binding.

Keep Researching

Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.

Research Peptides Category
Updated March 2026. This comparison is reviewed for catalog accuracy, sourcing language, and consistency with our public quality standards. It is an educational summary for research reference only. Read our Editorial Standards.

Ready to order?

Pick your product and check out in under 3 minutes.

Shop Now